Add to watchlist
€300.0
Last updated:07/30/2021
0QF: F
Moderna, Inc

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical … Show more

P/E ratio
237.72x
vs. 14.18x forward

Price is 237.72x times more than EPS €1.26 which eaquals €300.0

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Mr. Stephane Bancel
Market capitalization
Mega (122.26B)